Refractory Nivolumab-Induced Myasthenia Gravis Treated With Abatacept.

Khokher, Waleed; Bhuta, Sapan; Kesireddy, Nithin; Abuhelwa, Ziad; Mhanna, Mohammed; Iftikhar, Saffa; Horen, Nicholas; Assaly, Ragheb

Khokher, Waleed; Bhuta, Sapan; Kesireddy, Nithin; Abuhelwa, Ziad; Mhanna, Mohammed; Iftikhar, Saffa; Horen, Nicholas; Assaly, Ragheb.

Afiliación

Khokher W; University of Toledo Internal Medicine, Toledo, OH.
Bhuta S; University of Toledo Internal Medicine, Toledo, OH.
Kesireddy N; University of Toledo Internal Medicine, Toledo, OH.
Abuhelwa Z; University of Toledo Internal Medicine, Toledo, OH.
Mhanna M; University of Toledo Internal Medicine, Toledo, OH.
Iftikhar S; University of Toledo Internal Medicine, Toledo, OH.
Horen N; University of Toledo Internal Medicine, Toledo, OH.
Assaly R; University of Toledo Pulmonary and Critical Care Medicine, Toledo, OH.

Am J Ther ; 29(5): e576-e577, 2022.

Article en En | MEDLINE | ID: mdl-34264884

Asunto(s)

Miastenia Gravis; Nivolumab; Abatacept; Anticuerpos Monoclonales/efectos adversos; Humanos; Miastenia Gravis/inducido químicamente; Miastenia Gravis/tratamiento farmacológico; Nivolumab/efectos adversos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Nivolumab / Miastenia Gravis Límite: Humans Idioma: En Revista: Am J Ther Asunto de la revista: TERAPEUTICA Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google